Edition:
United Kingdom

Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

36.56USD
13 Sep 2019
Change (% chg)

$-0.18 (-0.49%)
Prev Close
$36.74
Open
$36.84
Day's High
$38.17
Day's Low
$36.54
Volume
134,431
Avg. Vol
180,335
52-wk High
$60.98
52-wk Low
$33.13

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.98 -2.011
Mar '19 145.42 3.071
FY 2018 Dec '18 0.00 -2.239
Sep '18 0.00 -1.862
Jun '18 0.00 -1.707
Mar '18 0.00 -1.734
FY 2017 Dec '17 0.00 -1.444
Sep '17 0.00 -1.860
Jun '17 0.00 -1.918
Mar '17 0.00 -1.797
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 11 0.81 1.10 0.00 0.00
Quarter Ending Dec-19 11 0.81 1.10 0.00 0.00
Year Ending Dec-19 10 148.00 149.00 146.40 27.78
Year Ending Dec-20 11 174.08 236.10 86.62 47.44
Earnings (per share)
Quarter Ending Sep-19 12 -1.94 -1.53 -2.27 -1.30
Quarter Ending Dec-19 12 -2.06 -1.70 -2.68 -1.30
Year Ending Dec-19 12 -2.77 -2.04 -3.75 -5.11
Year Ending Dec-20 11 -3.67 -1.77 -7.90 -5.89
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.39 32.66
P/E High - Last 5 Yrs. -- 147.53 47.31
P/E Low - Last 5 Yrs. -- 47.83 23.88
Beta 2.67 1.08 0.89
Price to Sales (TTM) -- 49.44 7.91
Price to Book (MRQ) 8.24 10.14 5.38
Price to Tangible Book (MRQ) 9.37 13.75 6.71
Price to Cash Flow (TTM) -- 55.95 24.36
% Owned Institutions -- 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.58 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 49.07 7.74
Sales - 5 Yr. Growth Rate -- 22.80 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -208.10 76.36 42.97
EPS (TTM) vs TTM 1 Yr. Ago -138.27 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.31
Capital Spending - 5 Yr. Growth Rate 22.82 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 5.52 3.59 3.03
LT Debt to Equity (MRQ) 0.09 18.57 10.20
Total Debt to Equity (MRQ) 1.24 31.19 14.55
Interest Coverage (TTM) -120.23 -44.62 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.09 52.24
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.43 13.12
Operating Margin (TTM) -- -183.67 6.81
Operating Margin - 5 Yr. Avg. -- -126.86 8.92
Pre-Tax Margin (TTM) -- -174.38 5.99
Pre-Tax Margin - 5 Yr. Avg. -- -132.62 9.22
Net Profit Margin (TTM) -- -181.07 2.63
Net Profit Margin - 5 Yr. Avg. -- -137.00 5.58
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,668,830 887,293,452
Net Income/Employee (TTM) -2,959,909 533,008 101,845,288
Receivable Turnover (TTM) -- 6.23 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.00 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.29 6.40 11.17
Return on Assets - 5 Yr. Avg. -30.70 5.50 12.34
Return on Investment (TTM) -61.42 8.95 14.48
Return on Investment - 5 Yr. Avg. -32.77 6.82 16.02
Return on Equity (TTM) -61.71 10.09 15.78
Return on Equity - 5 Yr. Avg. -35.99 8.46 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -47.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Esperion Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.55 7.70 99 98
13 Week 20.24 14.38 99 95
26 Week 56.92 44.99 99 97
52 Week 315.45 252.13 99 71
YTD 348.96 294.28 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 224
Total Shares Held: 30,384,863
3 Mo. Net Change: 781,789
# New Positions: 38
# Closed Positions: 25
# Increased Positions: 116
# Reduced Positions: 72
# Net Buyers: 44
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.